ARDX
Ardelyx, Inc. · Healthcare
Chief Development Officer David P. Rosenbaum sold $34K of Ardelyx, Inc.
Sold$34,447
$6.07Price
5,675Shares
−1%Stake
What ARDX did after the filing
- The stock from Wed, Dec 20 close, $5.94
- +50.8%
- S&P 500, same days
- +5.2%
Measured over 30 trading days, to the Feb 5 close.
Traded Mon, Dec 18. Filed Wed, Dec 20, 11:49 AM ET, during the session. Returns use the Dec 20 close and the Feb 5 close. Not investment advice.